Orbimed Advisors LLC Abbott Laboratories Transaction History

Orbimed Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $44.9 Million - $65.7 Million	-715,100 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $8.42 Million - $9.38 Million	-107,300 Reduced 13.05%	715,100 $62.1 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $9.46 Million - $10.3 Million	-115,600 Reduced 12.32%	822,400 $68.8 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $23.5 Million - $27.4 Million	322,600 Added 52.42%	938,000 $78.9 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $11.1 Million - $13.4 Million	167,000 Added 37.24%	615,400 $49.2 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.56 Million - $4.03 Million	54,300 Added 13.78%	448,400 $32.4 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $22.2 Million - $25.1 Million	394,100 New	394,100 $23.6 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.